We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Academy guidance on data analytics: Preparing clinical labs for a data-driven future

By Jen A. Miller
Posted on 30 Jun 2026

Data analytics is becoming increasingly important for clinical laboratories, but not everyone, or every institution, is at the same stage of their digital transformation. More...

How does someone interested in making their clinical laboratory more data-friendly take the next step? What’s the best way to get involved in a program that’s already started but may be floundering? 

A new guidance document from the Academy of Diagnostics & Laboratory Medicine was created to answer these questions, and a scientific session at ADLM 2026 on July 28 will highlight the key takeaways.

The document, which is currently in the public-comment phase, seeks to help clinical laboratorians figure out how to use its data in a meaningful way, wherever they may be in their data-analytics journey, said Thomas Durant, MD, associate professor of laboratory medicine and biomedical informatics and data science at the Yale School of Medicine, and corresponding author of the Academy Guidance Document. It offers a high-level overview of the essential components required to establish robust data-analytics programs within institutions.

Durant will also present at the ADLM 2026 session, along with Patrick Mathias, MD, PhD, associate professor and associate medical director of the informatics division in the department of laboratory medicine and pathology at the University of Washington School of Medicine in Seattle, Washington; and Sarah Wheeler, PhD, FADLM, CC(NRCC), chair of ADLM’s Data Analytics Steering Committee and associate professor of pathology at the University of Pittsburg, who is also a coauthor of the document.

“Data analytics is one of the things almost all institutions are dealing with now in some way, shape, or form,” Durant said.

“[The Academy Guidance Document addresses] all the big questions that you’re probably going to want to answer when embarking on a data-analytics journey,” Durant added. It’s designed to help people and institutions at different stages on that path, whether they’re still doing work on paper and Excel, or if their institution already has an analytics infrastructure in place.

In their presentation, Durant and team will tackle three main topics:

1.Why to build a data analytics program.

2. What resources are required, including available infrastructure tools and governance policies.

3. How to operate programs with good practice principles, with ethics and patient safety front of mind.

The presenters will make recommendations that will help laboratorians enhance their analytical capabilities and fully leverage their laboratory’s data assets, whether through independent departmental initiatives or collaborative partnerships with their organization’s leadership.

The session will offer something for everyone, Durant said. Participants don’t need to have a background in coding or computer science to attend. In fact, he hopes those who are new to data analytics will come to the session so they can see how accessible today’s tools are for people at all experience levels. “At my institution, some people who use data most in their everyday lives can’t code a lick, but they know their data,” he said. 

Like it or not, institutional change is coming. “It’s really about having someone who’s an analytics champion in the lab,” Durant said. Knowing how to talk to people who can build that architecture can help you communicate your vision, because successful programs require coordinating the people who know how to make that happen.

Overall, Durant hopes this session will help people realize that data analytics is foundational to the future of healthcare. As much as machine learning and artificial intelligence (AI) are hyped as revolutionary technologies, they cannot be implemented without the right data infrastructure in place. “AI is the Ferrari engine, but you have to design this whole fancy car around it to take advantage of it,” he said. The Academy’s new document and the Annual Meeting session will provide that vital framework.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Automated Immunoassay Analyzer
SuperFlex™
New
Drug Testing Assays
Atellica DT 250 Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Age-Based Genetic Testing May Miss Most Inherited Cancer Risk Variants

Inherited cancer risk can influence diagnosis, treatment planning, and family screening, yet current testing practices often depend on a patient’s age at diagnosis. Many patients undergo germline genetic... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.